Los Angeles, CA, July 18, 2019 (GLOBE NEWSWIRE) -- ICOx Innovations Inc. (“ICOx”)(TSXV and OTCQB: ICOX), which designs, builds and manages digital currencies so organizations can grow their businesses by attracting, engaging and retaining customers through the creation of their own digital currency, provided a recap of company and partner… Read More..

CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Exicure, Inc. (XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, today announced its appointment of Jeffrey L. Cleland, Ph.D. and Timothy P. Walbert to its Board of Directors. “We are excited to welcome two high caliber leaders like… Read More..

Los Angeles, CA, July 18, 2019 (GLOBE NEWSWIRE) -- ICOx Innovations Inc. (“ICOx”)(TSXV and OTCQB: ICOX), which designs, builds and manages digital currencies so organizations can grow their businesses by attracting, engaging and retaining customers through the creation of their own digital currency, provided a recap of company and partner… Read More..